The Association Between the Use of Oclacitinib and Antibacterial Therapy in Dogs With Allergic Dermatitis: A Retrospective Case-Control Study
Background: Canine allergic dermatitis, including atopic dermatitis, often requires antibacterial therapy for concurrent infections. Oclacitinib is indicated for treatment of pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis in dogs aged ≥12 months.Hyp...
Main Authors: | Hester Rynhoud, Justine S. Gibson, Erika Meler, Ricardo J. Soares Magalhães |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2021.631443/full |
Similar Items
-
The effects of oclacitinib treatment on antimicrobial usage in allergic dogs in primary practice: an Australia wide case-control study
by: Hester Rynhoud, et al.
Published: (2022-04-01) -
Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
by: Marike Visser, et al.
Published: (2022-03-01) -
Diminished antimicrobial drug use in dogs with allergic dermatitis treated with oclacitinib
by: Kennedy Mwacalimba, et al.
Published: (2023-09-01) -
Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue Sarcoma
by: Laura V. Ashton, et al.
Published: (2023-08-01) -
Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study
by: Laura E. Barrett, et al.
Published: (2019-08-01)